Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.
about
Regulatory T cells in arterivirus and coronavirus infections: do they protect against disease or enhance it?Modulatory role of regulatory T cells in a murine model of severe equine asthma.Cancer immunotherapy: the role regulatory T cells play and what can be done to overcome their inhibitory effects.Therapeutic vaccination with tumor cells that engage CD137.Two types of suppressor T cells that inhibit delayed-type hypersensitivity to Mycobacterium intracellulare in mice.Effects of cyclophosphamide and a metabolite, acrolein, on Naegleria fowleri in vitro and in vivo.Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscleRegulation of the immune response to tumor antigen.Regulatory T cells in the control of autoimmune diabetes: the case of the NOD mouse.Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance.Virus-replicating T cells in the immune response of mice. I. Virus plaque assay of the lymphocytes reactive to sheep erythrocytesInduction of a ragweed-specific allergic state in Ir-gene-restricted nonresponder miceNylon adherent antigen-specific rosette-forming T cells.In vivo effects of anti-Ia alloantisera. I. Elimination of specific suppression by in vivo administration of antisera specific for I-J controlled determinants.Differential cyclophosphamide sensitivity of precursor cells in allogeneic and H-2 restricted cytotoxic responses.Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice.Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine.Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. I. Genetic control of delayed-type hypersensitivity by VH and I-A-region genes.Site of action of serum factors that block delayed-type hypersensitivity in mice.Antigen- and receptor-driven regulatory mechanisms. I. Induction of suppressor T cells with anti-idiotypic antibodies.Role of antigen-presenting cells in the development and persistence of contact hypersensitivityDelayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice.T cell-dependent mast cell degranulation and release of serotonin in murine delayed-type hypersensitivity.Priming of T helper cells by antigen-activated B cells. B cell-primed Lyt-1+ helper cells are restricted to cooperate with B cells expressing the IgvH phenotype of the priming B cellsMechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression.Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppressionHapten-specific responses to the phenyltrimethylamino hapten. III. Mice whose delayed-type hypersensitivity responses cannot be abrogated by the presence of anti-idiotypic suppressor T cells lack a critical modulatory T cell functionStudy on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.Study on cellular events in post-thymectomy autoimmune oophoritis in mice. II. Requirement of Lyt-1 cells in normal female mice for the prevention of oophoritis.Antiidiotypic immunity in interstitial nephritis. II. Rats developing anti-tubular basement membrane disease fail to make an antiidiotypic regulatory response: the modulatory role of an RT7.1+, OX8- suppressor T cell mechanism.Genetic control of specific immune suppression. IV. Responsiveness to the random copolymer L-glutamic acid50-L-tyrosine50 induced in BALB/c mice by cyclophosphamide.Required early complement activation in contact sensitivity with generation of local C5-dependent chemotactic activity, and late T cell interferon gamma: a possible initiating role of B cells.Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes.Presence of a macrophage-mediated suppressor cell mechanism during cell-mediated immune response in experimental visceral leishmaniasisInduction of delayed-type hypersensitivity to Leishmania major and the concomitant acceleration of disease development in progressive murine cutaneous leishmaniasis.Relationship between delayed hypersensitivity response and acquired cell-mediated immunity in C57BL/6J mice infected with Leishmania donovaniEffect of cyclophosphamide on the immune responsiveness of jirds infected with Brugia pahangiCutaneous unresponsiveness to Mycobacterium bovis BCG in intravenously infected mice.Pharmacological modulation of suppressor cell activity in mice with disseminated histoplasmosisSuppression of adoptive antituberculosis immunity by normal recipient animals.
P2860
Q27001221-2669834A-A450-4797-BE1D-08A1AD53AAFEQ33617780-DE167CDE-0210-4831-B08C-67D743C6DBA5Q35033249-5E008E3B-83A5-48BB-9FB4-AF6DD54C5073Q35071688-CAC8EA13-483A-47CC-BEAB-6038B8C19C9BQ35092263-2FA5FD0F-44E9-42A7-BDF3-B12E75570612Q35311874-A88816AF-E572-4229-9897-9B43DBA51CF1Q35835377-1547F126-6E7A-4D1C-8FDE-2C59B1E7E256Q36092841-C361C673-40EC-4978-BD5F-99ACB348FC8DQ36203572-384EF262-94E6-4E92-9D9C-7BA1FA02B956Q36269628-597C11D7-8065-4988-A82D-89130995136CQ36335139-CD17DEFD-7035-4AEF-A8FE-56E3D3DD3325Q36335637-E38BFCD8-35BB-4147-B698-D8072CAB0840Q36336221-09C3F0DC-588C-4D61-8216-E9BF2F1F5ACAQ36339965-254E8CCA-49EA-45A1-889C-442644AF6637Q36341051-B020E049-7019-4215-87D7-7C22C4E4A4BEQ36341321-5BB25AB3-1A31-432B-BBDE-4DC0E8428728Q36341441-7C9031F5-5C63-4484-8820-84CB58694664Q36341578-580376DB-2A2E-4E0F-838F-ABC699EC0AD2Q36341607-4C549773-09F6-49EE-AE57-173E01564018Q36342979-DA90F250-4C05-49C3-887B-55E477EE0057Q36343305-513C358F-3398-46C1-B9D2-FAE37291E27DQ36343479-95BB07D2-56FF-4F69-959A-051CBFB9A913Q36344142-BCE35BAA-1B14-430D-B522-08521271D23DQ36344815-83B8B714-17CB-4CC7-AF9F-82E235C352F6Q36345559-B0825A03-5278-4E7C-A6AE-F57B9D5E5051Q36346425-580FF184-2EDB-4798-B98E-B83907D7FE2AQ36346560-CE450509-DF52-4A31-9D29-8A85E3EB91C1Q36347151-12471B3E-674A-41FB-8BF7-23BBF2F8F5A0Q36347185-5D286867-D150-496D-A54E-918F00DA0FFFQ36348613-D94F0807-2383-41A3-9378-5F36704A6AEBQ36359648-2FC434EE-C16D-41A4-A05B-B6611564DE2DQ36380633-F91C43A5-5996-4432-AD0F-E16405798B18Q36563528-659AD684-E44E-4C27-8A90-65A8BBF48F1FQ37013350-C6839EDE-ED60-4E2C-B3D1-3D6FF038133FQ37017181-8175CD2A-5970-4027-B138-A9BF02DEE420Q37050449-8BB7CF40-B80A-4BEB-8B22-B2A9BBCD383EQ37099493-FC16F92A-9BB3-4BBF-B39F-E48E9B8E2FB0Q37106895-AD7A3A85-BFD2-4674-8ABD-DC4EC5110B1FQ37108970-AF82FDBF-0F5F-46EC-8821-806E16BE87ECQ37109514-0C3F810F-ECFE-4089-8AB9-B6A85709660C
P2860
Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
1975年论文
@zh
1975年论文
@zh-cn
name
Augmentation of delayed-type h ...... not affect antibody responses.
@en
type
label
Augmentation of delayed-type h ...... not affect antibody responses.
@en
prefLabel
Augmentation of delayed-type h ...... not affect antibody responses.
@en
P2093
P2860
P356
P1476
Augmentation of delayed-type h ...... not affect antibody responses.
@en
P2093
Askenase PW
Gershon RK
P2860
P304
P356
10.1084/JEM.141.3.697
P407
P577
1975-03-01T00:00:00Z